Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
Goldman Sachs' Favorite Mutual Funds Positions That Are Overweight the Russell 1000
Danaher (DHR) Benefits From Business Strength Amid Risks
Form 144 | Danaher(DHR.US) Insider Proposes to Sell 12.81 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 13, $Danaher(DHR.US)$ Insider Glenstone Foundation intends to sell 47,937 shares of its common stock on Aug 13, with a total market value of approximately $12.81 million.
Shareholders Should Be Pleased With Danaher Corporation's (NYSE:DHR) Price
BD Names Michael Feld as President of Life Sciences Segment
10 Health Care Stocks Whale Activity In Today's Session
Is Danaher Corporation (NYSE:DHR) the Best Undervalued Stock to Buy According to Jim Cramer?
Behind the Scenes of Danaher's Latest Options Trends
Insider Sale: Director Linda Filler Sells Shares of Danaher Corp (DHR)
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Danaher(DHR.US) Officer Sells US$4.53 Million in Common Stock
Danaher Stock (NYSE:DHR): Under the Radar Compounding Machine
Form 144 | Danaher(DHR.US) Officer Proposes to Sell 4.53 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 1, $Danaher(DHR.US)$ Officer McGrew Matthew intends to sell 16,172 shares of its common stock on Aug 1, with a total market value of approximately $4.53 million. McGrew
(DHR) - Analyzing Danaher's Short Interest
Boeing Investors Should Pump the Brakes on New CEO Ortberg. Look at GE's Larry Culp for Why. -- Barrons.com
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Express News | Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Senior Vice President of Corporate Development Daniel Raskas Sold A Bunch Of Shares In Danaher
Danaher Insider Sold Shares Worth $3,924,352, According to a Recent SEC Filing